...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
【24h】

Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties

机译:具有亲认知性能的虚拟筛选驱动的双5-HT6 / 5-HT2A受体配体的发现

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

A virtual screening campaign aimed at finding structurally new compounds active at 5-HT6R provided a set of candidates. Among those, one structure, 4-(5-{[(2-{5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl}ethyl) amino]methyl}furan-2-yl)phenol (1, 5-HT6R K-i = 91 nM), was selected as a hit for further optimization. As expected, the chemical scaffold of selected compound was significantly different from all the serotonin receptor ligands published to date. Synthetic efforts, supported by molecular modelling, provided 43 compounds representing different substitution patterns. The derivative 42, 4-(5-{[(2-{5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl}ethyl)amino]methyl}furan-2-yl)phenol (5-HT6R K-j= 25, 5-HT2AR K-i = 32 nM), was selected as a lead and showed a good brain/plasma concentration profile, and it reversed phencyclidine-induced memory impairment. Considering the unique activity profile, the obtained series might be a good starting point for the development of a novel antipsychotic or antidepressant with procognitive properties. (C) 2019 The Authors. Published by Elsevier Masson SAS.
机译:旨在在5-HT6R中找到有结构新化合物的虚拟筛选活动提供了一组候选者。其中,一种结构,4-(5 - {[(2- {5-氟-1H-吡咯,吡啶-3-基-3-基}乙基)氨基]甲基}呋喃-2-基)苯酚(1,5-HT6R ki = 91nm)被选择为进一步优化的命中。如预期的那样,选定化合物的化学支架与迄今为止发表的所有血清素受体配体显着不同。通过分子建模支持的合成努力提供了43种化合物,代表不同的替代图案。衍生物42,4-(5 - {[(2- {5-氟-1H-吡咯,吡啶-3-基-3-Y1}乙基)氨基]甲基}呋喃-2-基)苯酚(5 -HT6R kj = 25,5-HT2AR ki = 32nm)作为铅选择并显示出良好的脑/血浆浓度曲线,并逆转束缚杂环诱导的记忆损伤。考虑到独特的活动简介,所获得的系列可能是开发新的抗精神病或抗抑郁药的良好起点。 (c)2019年作者。由Elsevier Masson SA出版。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号